Left bundle branch area pacing with multimodal guidance vs. conventional pacing for heart failure with complete left bundle branch block
Official title: Clinical Efficacy and Safety of Left Bundle Branch Area Pacing Using Quantitative Guidance of Multimodal Data in the Treatment of Heart Failure: A Multicenter, Randomized Controlled Study
Run by Second Affiliated Hospital of Nanchang University · NCT07814612 · Data updated 2026-11-12
A multicenter trial tests whether using multimodal data to guide left bundle branch area pacing helps people with heart failure and complete left bundle branch block, compared with traditional biventricular pacing.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Second Affiliated Hospital of Nanchang University Academic / other |
| Locations | 1 site (Nanchang, Jiangxi) |
| Status | Recruiting |
| Started | March 1, 2024 |
| Main results expected | December 2026 |
| Study ends | December 2027 |
| Registry record updated | September 11, 2026 |
| Trial ID | NCT07814612 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18-80 with non-ischemic cardiomyopathy, LVEF ≤40%, complete LBBB, sinus rhythm, NYHA II–IV, and on optimized heart failure therapy.
✕Probably not a fit
Patients with ischemic cardiomyopathy, non-LBBB conduction patterns, atrial fibrillation, or those needing pacemaker replacement without reimplantation may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This multicenter randomized trial compares multimodal quantitative guidance for left bundle branch area pacing to conventional biventricular pacing in adults with non-ischemic cardiomyopathy, reduced ejection fraction, and complete left bundle branch block. Participants receive guideline-directed medical therapy and are followed to assess long-term outcomes. The study aims to determine if the multimodal approach improves pacing effectiveness and safety, addressing limitations of current single-center and non-randomized evidence. Lead placement is guided by a predefined multimodal data fusion system, with intraoperative and postoperative recording of pacing parameters. The trial seeks to establish whether this physiological pacing strategy can achieve superior cardiac synchrony and clinical endpoints.
Why it matters
Potential benefit: If successful, patients could experience improved heart function, fewer symptoms, and potentially fewer hospitalizations.
How similar studies have gone: Previous studies on left bundle branch area pacing have shown promise but largely lack high-quality multicenter randomized evidence for long-term outcomes.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 18-80 years; * Sinus rhythm, complete left bundle branch block (LBBB) fulfilling the Strauss criteria (QRS duration \>140 ms in men or \>130 ms in women); * Non-ischemic cardiomyopathy, left ventricular ejection fraction (LVEF) ≤40%, and New York Heart Association (NYHA) functional class II-IV; * Signed informed consent. * All enrolled patients received guideline-recommended pharmacological therapy for heart failure for at least 3 months. Exclusion Criteria: * Coronary CT-confirmed ischemic cardiomyopathy; * wide QRS complex with non-LBBB morphology, including right bundle branch block and nonspecific intraventricular conduction block; * persistent atrial fibrillation; * pacemaker replacement without reimplantation of ventricular leads; * patients with special conditions, such as pregnancy, gestation, and advanced malignancy. * All patients underwent detailed recording of electrophysiological pacing parameters intraoperatively and postoperatively, and monitoring for surgical complications.
Where it's running
-
Department of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Nanchang, Jiangxi, China Recruiting
Study contacts
- Study coordinator: Zhenyu Zhai, PHD
- Email: 13337107502@163.com
- Phone: +86 15079109953
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Longitudinal Assessment of Cardiac MRI Microstructure in Patients and Healthy People
This study tests advanced, non-contrast and extended clinical cardiac MRI techniques to see how heart tissue features differ between people with heart disease and healthy individuals.
-
Using Apple Watch data to predict heart failure outcomes
This study is testing if data from Apple Watches can help predict heart failure problems and the chances of needing to go back to the hospital for patients with heart failure.
-
Using radiotherapy to treat advanced heart failure
This study is testing if a single low dose of radiation therapy can help people with advanced heart failure feel better and improve their heart function.
-
Study of heart conditions using advanced imaging techniques
This study is trying to find out what causes different heart conditions in Hispanic and African American people in the Bronx by using advanced imaging techniques.
-
Evaluating coronary microvascular dysfunction in heart failure patients
This study is trying to see if problems with tiny blood vessels in the heart affect how well people with heart failure can improve their heart function after treatment.
-
Comparing Biventricular Pacing and Left Bundle Branch Pacing for Heart Failure
This study is testing whether a new way of pacing the heart can help people with heart failure feel better and improve their heart function compared to the standard method.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.